Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

Genetic differences affect COVID-19 severity and treatment effectiveness.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

People with alopecia areata have a higher risk of stroke.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Inositol was not more effective than a placebo in treating trichotillomania.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Biologics for severe asthma have known side effects, but some new risks need more study.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

More severe alopecia areata can lower quality of life.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Diabetics have lower essential element levels, which may contribute to diabetes, and certain plants might help manage it.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

Black patients are underrepresented in alopecia research, highlighting the need for more inclusive studies.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.